Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-10-24

Clinical Trial Update: Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating changes in PSMA expression in prostate cancer in response to hormonal therapy, including both castration-resistant and ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Castration Resistant Prostate Cancer, Castration Sensitive Prostate Cancer | Phase 4 | Status: RECRUITING